Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr;18(2):466-478.
doi: 10.1007/s11764-022-01232-w. Epub 2022 Aug 8.

Novel computerized neurocognitive test battery is sensitive to cancer-related cognitive deficits in survivors

Alexandra M Gaynor  1   2   3 , Anam Ahsan  4 , Duane Jung  5 , Elizabeth Schofield  4 , Yuelin Li  4 , Elizabeth Ryan  4 , Tim A Ahles  4 , James C Root  4
Affiliations

Novel computerized neurocognitive test battery is sensitive to cancer-related cognitive deficits in survivors

Alexandra M Gaynor et al. J Cancer Surviv. 2024 Apr.

Abstract

Purpose: There is increasing interest in developing new methods to improve sensitivity in detecting subtle cognitive deficits associated with cancer and its treatments. The current study aimed to evaluate the ability of a novel computerized battery of cognitive neuroscience-based tests to discriminate between cognitive performance in breast cancer survivors and controls.

Methods: Breast cancer survivors (N = 174) and age-matched non-cancer controls (N = 183) completed the Enformia Cogsuite Battery of cognitive assessments, comprised of 7 computerized tests of multiple cognitive domains. Primary outcome measures included accuracy, reaction times (RT), and coefficients of variation (CV) for each task, as well as global scores of accuracy, RT, and CV aggregated across tests.

Results: Linear regressions adjusting for age, education, and remote vs. in-office administration showed that compared to non-cancer controls, survivors had significantly lower performance on measures of attention, executive function, working memory, verbal ability, visuospatial ability, and motor function. Survivors had significantly greater CV on measures of attention, working memory, and processing speed, and significantly slower RT on measures of verbal fluency.

Conclusions: The Cogsuite battery demonstrates sensitivity to cancer-related cognitive dysfunction across multiple domains, and is capable of identifying specific cognitive processes that may be affected in survivors.

Implications for cancer survivors: The sensitivity of these tasks to subtle cognitive deficits has advantages for initial diagnosis of cancer-related cognitive dysfunction, as well as detecting changes in survivors' cognitive function over time. The remote delivery of the battery may help overcome barriers associated with in-office administration and increase access to neurocognitive evaluation.

Keywords: Breast cancer; Cancer-related cognitive dysfunction; Cognitive impairment; Survivorship.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest Duane Jung is the CEO of the Enformia, Inc., the publisher of the Cogsuite battery. All other authors certify that they have no conflicts of interest to disclose.

Figures

Fig. 1
Fig. 1
Examples of trials on each of the computerized cognitive tasks in the Cogsuite battery
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Koppelmans V, Breteler MMB, Boogerd W, Seynaeve C, Gundy C, Schagen S. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. J Clin Oncol. 2012;30(10):1080–6. - PubMed
    1. Ahles TA, Root JC, Ryan EL. Cancer- and cancer treatment-associated cognitive changes: an update on the state of the science. J Clin Oncol. 2012;30:3675–86. - PMC - PubMed
    1. Vardy J, Wefel JS, Ahles TA, Tannock IF, Schagen SB. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol. 2007;19:623–9. 10.1093/annonc/mdm500. - DOI - PubMed
    1. Ahles TA, Root JC. Cognitive effects of cancer and cancer treatments. Annu Rev Clin Psychol. 2018;14:425–51. 10.1146/annurev-clinpsy-050817-084903. - DOI - PMC - PubMed
    1. Horowitz TS, Suls J, Treviño M. A call for a neuroscience approach to cancer-related cognitive impairment. Trends Neurosci. 2018;41:493–6. 10.1016/j.tins.2018.05.001. - DOI - PubMed

Publication types

LinkOut - more resources